NICE chief executive knighted in New Year’s honours

Andrew Dillon, chief executive of the National Institute for Health and Clinical Excellence (NICE), has been knighted in the 2010 New Year’s Honours’ List for services to health care. He was awarded a CBE in 2003.
Sir Andrew has said: “I am very proud to be given this Honour. I’ve been lucky in my career, in hospital management and particularly at NICE, in having some great jobs and in working with some of the most dedicated and hard-working people in the NHS. I couldn’t have achieved what I have done without them.”
Sir Andrew graduated from the University of Manchester in 1975 and has held a number of senior management positions in the National Health Service, including general manager of the Royal Free Hospital and chief executive of St George's Healthcare NHS Trust, both London teaching hospitals. He joined NICE as its founding Chief Executive in 1999.
Sir Michael Rawlins, chairman of NICE, said: “Sir Andrew’s contributions to the NHS generally, and to NICE in particular, have been exceptional. His award of a knighthood is richly deserved and his colleagues in the Institute, as well as his army of admirers in the wider NHS, will bask in his reflected glory.”
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
Related content
- NICE recommendation for AstraZeneca's Calquence in chronic lymphocytic leukaemia populations
- NICE recommends Lilly's Emgality for chronic and episodic migraine
- NICE recommends venetoclax combo, a non-chemo option for untreated chronic lymphocytic leukaemia
- NICE gives go-ahead for Sandoz's Rizmoic to treat opioid-induced constipation
- NICE gives thumbs-up to Roche's Kadcyla in HER2+ breast cancer sub-population